More than 100 cyclists biked from Cambridge Common to the Massachusetts State House on Sunday, where they joined a tearful ...

AstraZeneca has allocated $3.5billion to expand its US manufacturing and research footprint by the end of 2026. The funding ...

In the US, AstraZeneca has approximately 17,800 employees working across 17 R&D, manufacturing and commercial sites spanning ...

Cambridge: AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company's research and manufacturing footprint by the end of 2026.

It came as AZ reported its third-quarter results, headlined by a 20% increase in revenues to $12.95 billion, which will be discussed in full at a meeting today, along with other pressing matters, such ...

AstraZeneca, headquartered in Cambridge UK but globally influential, is investing $3.5 billion in the United States to expand ...

British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday a $3.5 billion capital investment in the United States, aiming to ...

AstraZeneca on Tuesday revealed that it’s adding $2 billion more to its current outlay in the U.S., representing a total ...

AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion ...

AstraZeneca’s expanding footprint in the US includes, among others: A research and development, R&D, center in Kendall Square, Cambridge, Massachusetts; A next generation manufacturing facility for ...

Porter Square is sometimes overshadowed by its neighbors Davis and Harvard Square, but it has a lot to offer. While many ...